JP2014524010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524010A5 JP2014524010A5 JP2014511600A JP2014511600A JP2014524010A5 JP 2014524010 A5 JP2014524010 A5 JP 2014524010A5 JP 2014511600 A JP2014511600 A JP 2014511600A JP 2014511600 A JP2014511600 A JP 2014511600A JP 2014524010 A5 JP2014524010 A5 JP 2014524010A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- antibody
- recombinant
- group
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 80
- 229920001184 polypeptide Polymers 0.000 claims description 79
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 79
- 102100022641 Coagulation factor IX Human genes 0.000 claims description 52
- 108010076282 Factor IX Proteins 0.000 claims description 52
- 229960004222 factor ix Drugs 0.000 claims description 52
- 108010054218 Factor VIII Proteins 0.000 claims description 48
- 102000001690 Factor VIII Human genes 0.000 claims description 48
- 229960000301 factor viii Drugs 0.000 claims description 48
- 230000000694 effects Effects 0.000 claims description 31
- -1 lymphokine Proteins 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 18
- 108010054265 Factor VIIa Proteins 0.000 claims description 16
- 229940012414 factor viia Drugs 0.000 claims description 16
- 230000012010 growth Effects 0.000 claims description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 12
- 210000000988 bone and bone Anatomy 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004127 Cytokines Human genes 0.000 claims description 10
- 108090000695 Cytokines Proteins 0.000 claims description 10
- 230000000921 morphogenic effect Effects 0.000 claims description 10
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 9
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 9
- 102000036693 Thrombopoietin Human genes 0.000 claims description 9
- 108010041111 Thrombopoietin Proteins 0.000 claims description 9
- 108010014172 Factor V Proteins 0.000 claims description 8
- 108010014173 Factor X Proteins 0.000 claims description 8
- 102000029947 transforming growth factor beta binding proteins Human genes 0.000 claims description 8
- 108091014793 transforming growth factor beta binding proteins Proteins 0.000 claims description 8
- 108010074864 Factor XI Proteins 0.000 claims description 7
- 108010080865 Factor XII Proteins 0.000 claims description 7
- 102000000429 Factor XII Human genes 0.000 claims description 7
- 108010000499 Thromboplastin Proteins 0.000 claims description 7
- 102000002262 Thromboplastin Human genes 0.000 claims description 7
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 7
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 7
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 claims description 6
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 claims description 6
- 102000003956 Fibroblast growth factor 8 Human genes 0.000 claims description 6
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 claims description 6
- 102000004877 Insulin Human genes 0.000 claims description 6
- 108090001061 Insulin Proteins 0.000 claims description 6
- 108010047761 Interferon-alpha Proteins 0.000 claims description 6
- 102000006992 Interferon-alpha Human genes 0.000 claims description 6
- 102100030703 Interleukin-22 Human genes 0.000 claims description 6
- 108090001007 Interleukin-8 Proteins 0.000 claims description 6
- 102000004890 Interleukin-8 Human genes 0.000 claims description 6
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 6
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 6
- 108090000190 Thrombin Proteins 0.000 claims description 6
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 6
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- 229940125396 insulin Drugs 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 229960004072 thrombin Drugs 0.000 claims description 6
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims description 6
- 102100036537 von Willebrand factor Human genes 0.000 claims description 6
- 108091005670 ADAMTS13 Proteins 0.000 claims description 5
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 claims description 5
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 claims description 5
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 5
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 5
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims description 5
- 102100035194 Placenta growth factor Human genes 0.000 claims description 5
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims description 5
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims description 5
- 101800004937 Protein C Proteins 0.000 claims description 5
- 102000017975 Protein C Human genes 0.000 claims description 5
- 101800001700 Saposin-D Proteins 0.000 claims description 5
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 5
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 5
- 229960000856 protein c Drugs 0.000 claims description 5
- 229960005356 urokinase Drugs 0.000 claims description 5
- 108010047303 von Willebrand Factor Proteins 0.000 claims description 5
- 229960001134 von willebrand factor Drugs 0.000 claims description 5
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 4
- 108010050904 Interferons Proteins 0.000 claims description 4
- 102000014150 Interferons Human genes 0.000 claims description 4
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 claims description 4
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 claims description 4
- 108010066124 Protein S Proteins 0.000 claims description 4
- 102000029301 Protein S Human genes 0.000 claims description 4
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 4
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 4
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 4
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 4
- 229940079322 interferon Drugs 0.000 claims description 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 4
- 229960000187 tissue plasminogen activator Drugs 0.000 claims description 4
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 claims description 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 3
- 102000043853 ADAMTS13 Human genes 0.000 claims description 3
- 108010059616 Activins Proteins 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 3
- 102100022987 Angiogenin Human genes 0.000 claims description 3
- 108010081589 Becaplermin Proteins 0.000 claims description 3
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 3
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 3
- 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 claims description 3
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims description 3
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims description 3
- 102100028728 Bone morphogenetic protein 1 Human genes 0.000 claims description 3
- 108090000654 Bone morphogenetic protein 1 Proteins 0.000 claims description 3
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 3
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 claims description 3
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 3
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims description 3
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 3
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 3
- 102100028892 Cardiotrophin-1 Human genes 0.000 claims description 3
- 101710161573 Cardiotrophin-2 Proteins 0.000 claims description 3
- 108010008951 Chemokine CXCL12 Proteins 0.000 claims description 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 3
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 3
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 claims description 3
- 108010000063 Ciliary Neurotrophic Factor Receptor Proteins 0.000 claims description 3
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 claims description 3
- 102100031615 Ciliary neurotrophic factor receptor subunit alpha Human genes 0.000 claims description 3
- 102400000686 Endothelin-1 Human genes 0.000 claims description 3
- 101800004490 Endothelin-1 Proteins 0.000 claims description 3
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 3
- 102100030323 Epigen Human genes 0.000 claims description 3
- 108010016906 Epigen Proteins 0.000 claims description 3
- 101800000155 Epiregulin Proteins 0.000 claims description 3
- 108010008165 Etanercept Proteins 0.000 claims description 3
- 102000004641 Fetal Proteins Human genes 0.000 claims description 3
- 108010003471 Fetal Proteins Proteins 0.000 claims description 3
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 3
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims description 3
- 102000004864 Fibroblast growth factor 10 Human genes 0.000 claims description 3
- 108090001047 Fibroblast growth factor 10 Proteins 0.000 claims description 3
- 102000014252 Fibroblast growth factor 11 Human genes 0.000 claims description 3
- 108050003237 Fibroblast growth factor 11 Proteins 0.000 claims description 3
- 102000014250 Fibroblast growth factor 12 Human genes 0.000 claims description 3
- 108050003239 Fibroblast growth factor 12 Proteins 0.000 claims description 3
- 102000012570 Fibroblast growth factor 16 Human genes 0.000 claims description 3
- 108050002072 Fibroblast growth factor 16 Proteins 0.000 claims description 3
- 102000012565 Fibroblast growth factor 17 Human genes 0.000 claims description 3
- 108050002074 Fibroblast growth factor 17 Proteins 0.000 claims description 3
- 102100031734 Fibroblast growth factor 19 Human genes 0.000 claims description 3
- 101710153349 Fibroblast growth factor 19 Proteins 0.000 claims description 3
- 102000012558 Fibroblast growth factor 20 Human genes 0.000 claims description 3
- 108050002085 Fibroblast growth factor 20 Proteins 0.000 claims description 3
- 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims description 3
- 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims description 3
- 102000003969 Fibroblast growth factor 4 Human genes 0.000 claims description 3
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 claims description 3
- 102000003967 Fibroblast growth factor 5 Human genes 0.000 claims description 3
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 claims description 3
- 102000003968 Fibroblast growth factor 6 Human genes 0.000 claims description 3
- 108090000382 Fibroblast growth factor 6 Proteins 0.000 claims description 3
- 102000003957 Fibroblast growth factor 9 Human genes 0.000 claims description 3
- 108090000367 Fibroblast growth factor 9 Proteins 0.000 claims description 3
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims description 3
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims description 3
- 102000004216 Glial cell line-derived neurotrophic factor receptors Human genes 0.000 claims description 3
- 108090000722 Glial cell line-derived neurotrophic factor receptors Proteins 0.000 claims description 3
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 3
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 claims description 3
- 101710194452 Growth/differentiation factor 11 Proteins 0.000 claims description 3
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 claims description 3
- 101710204281 Growth/differentiation factor 6 Proteins 0.000 claims description 3
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims description 3
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 3
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 claims description 3
- 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 claims description 3
- 102100026818 Inhibin beta E chain Human genes 0.000 claims description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims description 3
- 102100025947 Insulin-like growth factor II Human genes 0.000 claims description 3
- 102100026720 Interferon beta Human genes 0.000 claims description 3
- 102100037850 Interferon gamma Human genes 0.000 claims description 3
- 108090000467 Interferon-beta Proteins 0.000 claims description 3
- 108010074328 Interferon-gamma Proteins 0.000 claims description 3
- 102100020881 Interleukin-1 alpha Human genes 0.000 claims description 3
- 102000003777 Interleukin-1 beta Human genes 0.000 claims description 3
- 108090000193 Interleukin-1 beta Proteins 0.000 claims description 3
- 108090000174 Interleukin-10 Proteins 0.000 claims description 3
- 102000003814 Interleukin-10 Human genes 0.000 claims description 3
- 108090000177 Interleukin-11 Proteins 0.000 claims description 3
- 102000003815 Interleukin-11 Human genes 0.000 claims description 3
- 108010065805 Interleukin-12 Proteins 0.000 claims description 3
- 108090000176 Interleukin-13 Proteins 0.000 claims description 3
- 108090000172 Interleukin-15 Proteins 0.000 claims description 3
- 101800003050 Interleukin-16 Proteins 0.000 claims description 3
- 102000013691 Interleukin-17 Human genes 0.000 claims description 3
- 108050003558 Interleukin-17 Proteins 0.000 claims description 3
- 108090000171 Interleukin-18 Proteins 0.000 claims description 3
- 108050009288 Interleukin-19 Proteins 0.000 claims description 3
- 108010082786 Interleukin-1alpha Proteins 0.000 claims description 3
- 108010065637 Interleukin-23 Proteins 0.000 claims description 3
- 108010002386 Interleukin-3 Proteins 0.000 claims description 3
- 102000000646 Interleukin-3 Human genes 0.000 claims description 3
- 108010067003 Interleukin-33 Proteins 0.000 claims description 3
- 108090000978 Interleukin-4 Proteins 0.000 claims description 3
- 102000004388 Interleukin-4 Human genes 0.000 claims description 3
- 108010002616 Interleukin-5 Proteins 0.000 claims description 3
- 102000000743 Interleukin-5 Human genes 0.000 claims description 3
- 108090001005 Interleukin-6 Proteins 0.000 claims description 3
- 102000004889 Interleukin-6 Human genes 0.000 claims description 3
- 108010002586 Interleukin-7 Proteins 0.000 claims description 3
- 108010002335 Interleukin-9 Proteins 0.000 claims description 3
- 102000004856 Lectins Human genes 0.000 claims description 3
- 108090001090 Lectins Proteins 0.000 claims description 3
- 102000016267 Leptin Human genes 0.000 claims description 3
- 108010092277 Leptin Proteins 0.000 claims description 3
- 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 3
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 3
- 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 claims description 3
- 101710142062 Leukemia inhibitory factor receptor Proteins 0.000 claims description 3
- 108090001030 Lipoproteins Proteins 0.000 claims description 3
- 102000004895 Lipoproteins Human genes 0.000 claims description 3
- 102000009151 Luteinizing Hormone Human genes 0.000 claims description 3
- 108010073521 Luteinizing Hormone Proteins 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 3
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 3
- 108090000742 Neurotrophin 3 Proteins 0.000 claims description 3
- 102000004230 Neurotrophin 3 Human genes 0.000 claims description 3
- 102000003683 Neurotrophin-4 Human genes 0.000 claims description 3
- 108090000099 Neurotrophin-4 Proteins 0.000 claims description 3
- 108090000630 Oncostatin M Proteins 0.000 claims description 3
- 102000004140 Oncostatin M Human genes 0.000 claims description 3
- 102000015439 Phospholipases Human genes 0.000 claims description 3
- 108010064785 Phospholipases Proteins 0.000 claims description 3
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 claims description 3
- 101710148465 Platelet-derived growth factor receptor alpha Proteins 0.000 claims description 3
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 3
- 101710164680 Platelet-derived growth factor receptor beta Proteins 0.000 claims description 3
- 101710103506 Platelet-derived growth factor subunit A Proteins 0.000 claims description 3
- 102100037596 Platelet-derived growth factor subunit A Human genes 0.000 claims description 3
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 claims description 3
- 101710103494 Platelet-derived growth factor subunit B Proteins 0.000 claims description 3
- 102100033237 Pro-epidermal growth factor Human genes 0.000 claims description 3
- 102100025498 Proepiregulin Human genes 0.000 claims description 3
- 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 claims description 3
- 102000003946 Prolactin Human genes 0.000 claims description 3
- 108010057464 Prolactin Proteins 0.000 claims description 3
- 229940096437 Protein S Drugs 0.000 claims description 3
- 101710150593 Protein beta Proteins 0.000 claims description 3
- 101710179016 Protein gamma Proteins 0.000 claims description 3
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims description 3
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims description 3
- 102100032350 Protransforming growth factor alpha Human genes 0.000 claims description 3
- 101500026849 Rattus norvegicus C3a anaphylatoxin Proteins 0.000 claims description 3
- 102000004584 Somatomedin Receptors Human genes 0.000 claims description 3
- 108010017622 Somatomedin Receptors Proteins 0.000 claims description 3
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 3
- 102100031372 Thymidine phosphorylase Human genes 0.000 claims description 3
- 108700023160 Thymidine phosphorylases Proteins 0.000 claims description 3
- 102000004338 Transferrin Human genes 0.000 claims description 3
- 108090000901 Transferrin Proteins 0.000 claims description 3
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 claims description 3
- 101800004564 Transforming growth factor alpha Proteins 0.000 claims description 3
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 claims description 3
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims description 3
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims description 3
- 102100040247 Tumor necrosis factor Human genes 0.000 claims description 3
- 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims description 3
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims description 3
- 102100035140 Vitronectin Human genes 0.000 claims description 3
- 108010031318 Vitronectin Proteins 0.000 claims description 3
- 239000000488 activin Substances 0.000 claims description 3
- 108010023082 activin A Proteins 0.000 claims description 3
- 108010023079 activin B Proteins 0.000 claims description 3
- 229960002964 adalimumab Drugs 0.000 claims description 3
- 229940050528 albumin Drugs 0.000 claims description 3
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 3
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 3
- 108010072788 angiogenin Proteins 0.000 claims description 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 3
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 claims description 3
- 108010041776 cardiotrophin 1 Proteins 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 229940015047 chorionic gonadotropin Drugs 0.000 claims description 3
- 229960001251 denosumab Drugs 0.000 claims description 3
- 229940116977 epidermal growth factor Drugs 0.000 claims description 3
- 229940011871 estrogen Drugs 0.000 claims description 3
- 239000000262 estrogen Substances 0.000 claims description 3
- 229960000403 etanercept Drugs 0.000 claims description 3
- 102000013361 fetuin Human genes 0.000 claims description 3
- 108060002885 fetuin Proteins 0.000 claims description 3
- 102000003684 fibroblast growth factor 13 Human genes 0.000 claims description 3
- 108090000047 fibroblast growth factor 13 Proteins 0.000 claims description 3
- 229940098448 fibroblast growth factor 7 Drugs 0.000 claims description 3
- 229940028334 follicle stimulating hormone Drugs 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- 239000000411 inducer Substances 0.000 claims description 3
- 102000028416 insulin-like growth factor binding Human genes 0.000 claims description 3
- 108091022911 insulin-like growth factor binding Proteins 0.000 claims description 3
- 102000006495 integrins Human genes 0.000 claims description 3
- 108010044426 integrins Proteins 0.000 claims description 3
- 102000004114 interleukin 20 Human genes 0.000 claims description 3
- 108090000681 interleukin 20 Proteins 0.000 claims description 3
- 108010074108 interleukin-21 Proteins 0.000 claims description 3
- 108010074109 interleukin-22 Proteins 0.000 claims description 3
- 239000002523 lectin Substances 0.000 claims description 3
- 229940039781 leptin Drugs 0.000 claims description 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims description 3
- 229940040129 luteinizing hormone Drugs 0.000 claims description 3
- 229960003646 lysine Drugs 0.000 claims description 3
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims description 3
- 229940053128 nerve growth factor Drugs 0.000 claims description 3
- 229940032018 neurotrophin 3 Drugs 0.000 claims description 3
- 229940097998 neurotrophin 4 Drugs 0.000 claims description 3
- 210000000440 neutrophil Anatomy 0.000 claims description 3
- 108010000685 platelet-derived growth factor AB Proteins 0.000 claims description 3
- 229940097325 prolactin Drugs 0.000 claims description 3
- 229940092597 prolia Drugs 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 230000002992 thymic effect Effects 0.000 claims description 3
- 239000012581 transferrin Substances 0.000 claims description 3
- 229940072041 transforming growth factor beta 2 Drugs 0.000 claims description 3
- 108010033898 transforming growth factor beta1.2 Proteins 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 claims description 2
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 2
- 102100028726 Bone morphogenetic protein 10 Human genes 0.000 claims description 2
- 101710118482 Bone morphogenetic protein 10 Proteins 0.000 claims description 2
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 claims description 2
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims description 2
- 102000018150 Glial cell line-derived neurotrophic factor receptor alpha 2 Human genes 0.000 claims description 2
- 108050007263 Glial cell line-derived neurotrophic factor receptor alpha 2 Proteins 0.000 claims description 2
- 108010090290 Growth Differentiation Factor 2 Proteins 0.000 claims description 2
- 102100040892 Growth/differentiation factor 2 Human genes 0.000 claims description 2
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 claims description 2
- 101710204282 Growth/differentiation factor 5 Proteins 0.000 claims description 2
- 101710181613 Interleukin-31 Proteins 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 102000013566 Plasminogen Human genes 0.000 claims description 2
- 108010051456 Plasminogen Proteins 0.000 claims description 2
- 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 claims description 2
- 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 claims description 2
- 102000013275 Somatomedins Human genes 0.000 claims description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 2
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 2
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 2
- 108010063130 Type II Bone Morphogenetic Protein Receptors Proteins 0.000 claims description 2
- 102000010571 Type II Bone Morphogenetic Protein Receptors Human genes 0.000 claims description 2
- 102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 claims description 2
- 108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 229940048921 humira Drugs 0.000 claims description 2
- 108090000237 interleukin-24 Proteins 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 210000004698 lymphocyte Anatomy 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 102100023804 Coagulation factor VII Human genes 0.000 claims 50
- 108010023321 Factor VII Proteins 0.000 claims 50
- 229940012413 factor vii Drugs 0.000 claims 50
- 239000000523 sample Substances 0.000 claims 37
- 230000004048 modification Effects 0.000 claims 35
- 238000012986 modification Methods 0.000 claims 35
- 238000001514 detection method Methods 0.000 claims 25
- 239000003795 chemical substances by application Substances 0.000 claims 23
- 238000003556 assay Methods 0.000 claims 20
- 108010048049 Factor IXa Proteins 0.000 claims 10
- 108010061932 Factor VIIIa Proteins 0.000 claims 10
- 229920001223 polyethylene glycol Polymers 0.000 claims 10
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims 6
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims 6
- 108010029144 Factor IIa Proteins 0.000 claims 6
- 108010094028 Prothrombin Proteins 0.000 claims 6
- 239000003114 blood coagulation factor Substances 0.000 claims 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical group [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims 6
- 238000002360 preparation method Methods 0.000 claims 6
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical group [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 5
- 108090000394 Erythropoietin Proteins 0.000 claims 4
- 102000003951 Erythropoietin Human genes 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 4
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 4
- 229920002472 Starch Chemical group 0.000 claims 4
- 229940105423 erythropoietin Drugs 0.000 claims 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 4
- 239000010452 phosphate Substances 0.000 claims 4
- 229920000765 poly(2-oxazolines) Polymers 0.000 claims 4
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 4
- 229920001515 polyalkylene glycol Polymers 0.000 claims 4
- 229920001451 polypropylene glycol Polymers 0.000 claims 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 4
- 239000008107 starch Chemical group 0.000 claims 4
- 102000004506 Blood Proteins Human genes 0.000 claims 3
- 108010017384 Blood Proteins Proteins 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 235000019698 starch Nutrition 0.000 claims 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 2
- 102100032290 A disintegrin and metalloproteinase with thrombospondin motifs 13 Human genes 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 108090000371 Esterases Proteins 0.000 claims 2
- 108010074860 Factor Xa Proteins 0.000 claims 2
- 108010000487 High-Molecular-Weight Kininogen Proteins 0.000 claims 2
- 102100035792 Kininogen-1 Human genes 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 102000004179 Plasminogen Activator Inhibitor 2 Human genes 0.000 claims 2
- 108090000614 Plasminogen Activator Inhibitor 2 Proteins 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 229920001218 Pullulan Polymers 0.000 claims 2
- 239000004373 Pullulan Substances 0.000 claims 2
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000010933 acylation Effects 0.000 claims 2
- 238000005917 acylation reaction Methods 0.000 claims 2
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 claims 2
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 claims 2
- 239000004019 antithrombin Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 125000000837 carbohydrate group Chemical group 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 230000006329 citrullination Effects 0.000 claims 2
- 238000010494 dissociation reaction Methods 0.000 claims 2
- 230000005593 dissociations Effects 0.000 claims 2
- 230000010437 erythropoiesis Effects 0.000 claims 2
- 229940088597 hormone Drugs 0.000 claims 2
- 239000005556 hormone Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 229940121354 immunomodulator Drugs 0.000 claims 2
- 230000002584 immunomodulator Effects 0.000 claims 2
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 claims 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 2
- 108010025221 plasma protein Z Proteins 0.000 claims 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 2
- 229920005646 polycarboxylate Polymers 0.000 claims 2
- 238000000746 purification Methods 0.000 claims 2
- 239000002516 radical scavenger Substances 0.000 claims 2
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical group CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 claims 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical group CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 claims 1
- DCPFJUYTSUMUFH-UHFFFAOYSA-N 2-aminoethanol;2,3-dihydroxypropyl dihydrogen phosphate Chemical group NCCO.OCC(O)COP(O)(O)=O DCPFJUYTSUMUFH-UHFFFAOYSA-N 0.000 claims 1
- 125000001572 5'-adenylyl group Chemical group C=12N=C([H])N=C(N([H])[H])C=1N=C([H])N2[C@@]1([H])[C@@](O[H])([H])[C@@](O[H])([H])[C@](C(OP(=O)(O[H])[*])([H])[H])([H])O1 0.000 claims 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical group FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 102100033639 Acetylcholinesterase Human genes 0.000 claims 1
- 108010022752 Acetylcholinesterase Proteins 0.000 claims 1
- 102100036664 Adenosine deaminase Human genes 0.000 claims 1
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 claims 1
- 102000004411 Antithrombin III Human genes 0.000 claims 1
- 108090000935 Antithrombin III Proteins 0.000 claims 1
- 108010024976 Asparaginase Proteins 0.000 claims 1
- 102000015790 Asparaginase Human genes 0.000 claims 1
- 238000009010 Bradford assay Methods 0.000 claims 1
- 108010053652 Butyrylcholinesterase Proteins 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 102100032404 Cholinesterase Human genes 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 108700040183 Complement C1 Inhibitor Proteins 0.000 claims 1
- 102000055157 Complement C1 Inhibitor Human genes 0.000 claims 1
- 229920000045 Dermatan sulfate Polymers 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102100031939 Erythropoietin Human genes 0.000 claims 1
- 108010074105 Factor Va Proteins 0.000 claims 1
- 108010071289 Factor XIII Proteins 0.000 claims 1
- 108010000196 Factor XIIIa Proteins 0.000 claims 1
- 108010071241 Factor XIIa Proteins 0.000 claims 1
- 108010080805 Factor XIa Proteins 0.000 claims 1
- 108010049003 Fibrinogen Proteins 0.000 claims 1
- 102000008946 Fibrinogen Human genes 0.000 claims 1
- 108010088842 Fibrinolysin Proteins 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 108090000481 Heparin Cofactor II Proteins 0.000 claims 1
- 102100030500 Heparin cofactor 2 Human genes 0.000 claims 1
- 102000004157 Hydrolases Human genes 0.000 claims 1
- 108090000604 Hydrolases Proteins 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 102000008934 Muscle Proteins Human genes 0.000 claims 1
- 108010074084 Muscle Proteins Proteins 0.000 claims 1
- 101710138657 Neurotoxin Proteins 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 108010067372 Pancreatic elastase Proteins 0.000 claims 1
- 102000016387 Pancreatic elastase Human genes 0.000 claims 1
- 102000057297 Pepsin A Human genes 0.000 claims 1
- 108090000284 Pepsin A Proteins 0.000 claims 1
- 108090000113 Plasma Kallikrein Proteins 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 230000006295 S-nitrosylation Effects 0.000 claims 1
- 102100026966 Thrombomodulin Human genes 0.000 claims 1
- 108010079274 Thrombomodulin Proteins 0.000 claims 1
- 102000004357 Transferases Human genes 0.000 claims 1
- 108090000992 Transferases Proteins 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 102000044159 Ubiquitin Human genes 0.000 claims 1
- 108090000848 Ubiquitin Proteins 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 230000021736 acetylation Effects 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 229940022698 acetylcholinesterase Drugs 0.000 claims 1
- 230000006154 adenylylation Effects 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 claims 1
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 239000003194 amino acid receptor blocking agent Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000002356 anti-selenium Effects 0.000 claims 1
- 229960005348 antithrombin iii Drugs 0.000 claims 1
- 230000010516 arginylation Effects 0.000 claims 1
- 229960003272 asparaginase Drugs 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims 1
- 210000000941 bile Anatomy 0.000 claims 1
- 230000029918 bioluminescence Effects 0.000 claims 1
- 238000005415 bioluminescence Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000006287 biotinylation Effects 0.000 claims 1
- 238000007413 biotinylation Methods 0.000 claims 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000006242 butyrylation Effects 0.000 claims 1
- 238000010514 butyrylation reaction Methods 0.000 claims 1
- 229940009550 c1 esterase inhibitor Drugs 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000021235 carbamoylation Effects 0.000 claims 1
- 150000001720 carbohydrates Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 238000000423 cell based assay Methods 0.000 claims 1
- 239000013592 cell lysate Substances 0.000 claims 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 230000035602 clotting Effects 0.000 claims 1
- 108010045487 coagulogen Proteins 0.000 claims 1
- 238000007398 colorimetric assay Methods 0.000 claims 1
- 238000003271 compound fluorescence assay Methods 0.000 claims 1
- 239000000287 crude extract Substances 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 230000006240 deamidation Effects 0.000 claims 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims 1
- 229940051593 dermatan sulfate Drugs 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- FOOBQHKMWYGHCE-UHFFFAOYSA-O diphthamide group Chemical group NC(CC=1N=C(NC1)CCC(C(N)=O)[N+](C)(C)C)C(=O)O FOOBQHKMWYGHCE-UHFFFAOYSA-O 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 230000006330 eliminylation Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 238000001952 enzyme assay Methods 0.000 claims 1
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 1
- 229960001123 epoprostenol Drugs 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 229940012444 factor xiii Drugs 0.000 claims 1
- 229940043259 farnesol Drugs 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 229940012952 fibrinogen Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 125000004072 flavinyl group Chemical group 0.000 claims 1
- 238000000684 flow cytometry Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 230000022244 formylation Effects 0.000 claims 1
- 238000006170 formylation reaction Methods 0.000 claims 1
- 230000006251 gamma-carboxylation Effects 0.000 claims 1
- 150000004676 glycans Polymers 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 125000003147 glycosyl group Chemical group 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical group CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000033444 hydroxylation Effects 0.000 claims 1
- 238000005805 hydroxylation reaction Methods 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000000099 in vitro assay Methods 0.000 claims 1
- 238000005462 in vivo assay Methods 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 229940010675 intramuscular immunoglobulin Drugs 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000026045 iodination Effects 0.000 claims 1
- 238000006192 iodination reaction Methods 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
- 230000006122 isoprenylation Effects 0.000 claims 1
- 125000003473 lipid group Chemical group 0.000 claims 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical group [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 1
- 230000006144 lipoylation Effects 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 claims 1
- 230000017538 malonylation Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 229940105132 myristate Drugs 0.000 claims 1
- 230000007498 myristoylation Effects 0.000 claims 1
- 230000009527 neddylation Effects 0.000 claims 1
- 239000002581 neurotoxin Substances 0.000 claims 1
- 231100000618 neurotoxin Toxicity 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 230000026792 palmitoylation Effects 0.000 claims 1
- 229940111202 pepsin Drugs 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 229940012957 plasmin Drugs 0.000 claims 1
- 230000010287 polarization Effects 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 230000001884 polyglutamylation Effects 0.000 claims 1
- 230000019474 polyglycylation Effects 0.000 claims 1
- 230000037048 polymerization activity Effects 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- 230000006267 polysialylation Effects 0.000 claims 1
- 239000013641 positive control Substances 0.000 claims 1
- 230000013823 prenylation Effects 0.000 claims 1
- 230000006289 propionylation Effects 0.000 claims 1
- 238000010515 propionylation reaction Methods 0.000 claims 1
- 235000019423 pullulan Nutrition 0.000 claims 1
- 230000019617 pupation Effects 0.000 claims 1
- 238000012205 qualitative assay Methods 0.000 claims 1
- 238000012207 quantitative assay Methods 0.000 claims 1
- 238000002165 resonance energy transfer Methods 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000006884 silylation reaction Methods 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 claims 1
- 230000035322 succinylation Effects 0.000 claims 1
- 238000010613 succinylation reaction Methods 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 230000019635 sulfation Effects 0.000 claims 1
- 238000005670 sulfation reaction Methods 0.000 claims 1
- 230000010741 sumoylation Effects 0.000 claims 1
- 150000003505 terpenes Chemical group 0.000 claims 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical group CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- 230000034512 ubiquitination Effects 0.000 claims 1
- 238000010798 ubiquitination Methods 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 101500026845 Rattus norvegicus C3-beta-c Proteins 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- 101001010152 Aplysia californica Probable glutathione transferase Proteins 0.000 description 1
- 102000003928 Bone morphogenetic protein 15 Human genes 0.000 description 1
- 108090000349 Bone morphogenetic protein 15 Proteins 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 102100031000 Hepatoma-derived growth factor Human genes 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 101100369076 Mus musculus Tdgf1 gene Proteins 0.000 description 1
- 101710151715 Protein 7 Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 108010070827 growth differentiation factor 7 Proteins 0.000 description 1
- 108010052188 hepatoma-derived growth factor Proteins 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002912 lymphogenic effect Effects 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161487612P | 2011-05-18 | 2011-05-18 | |
| US61/487,612 | 2011-05-18 | ||
| PCT/US2012/038704 WO2012159084A1 (en) | 2011-05-18 | 2012-05-18 | Modification-dependent activity assays |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017079848A Division JP2017161536A (ja) | 2011-05-18 | 2017-04-13 | 修飾依存的活性アッセイ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524010A JP2014524010A (ja) | 2014-09-18 |
| JP2014524010A5 true JP2014524010A5 (enExample) | 2015-07-02 |
| JP6175426B2 JP6175426B2 (ja) | 2017-08-02 |
Family
ID=46208807
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511600A Active JP6175426B2 (ja) | 2011-05-18 | 2012-05-18 | 修飾依存的活性アッセイ |
| JP2017079848A Pending JP2017161536A (ja) | 2011-05-18 | 2017-04-13 | 修飾依存的活性アッセイ |
| JP2018210141A Active JP6863950B2 (ja) | 2011-05-18 | 2018-11-08 | 修飾依存的活性アッセイ |
| JP2020208021A Active JP7242627B2 (ja) | 2011-05-18 | 2020-12-16 | 修飾依存的活性アッセイ |
| JP2023035124A Active JP7618714B2 (ja) | 2011-05-18 | 2023-03-08 | 修飾依存的活性アッセイ |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017079848A Pending JP2017161536A (ja) | 2011-05-18 | 2017-04-13 | 修飾依存的活性アッセイ |
| JP2018210141A Active JP6863950B2 (ja) | 2011-05-18 | 2018-11-08 | 修飾依存的活性アッセイ |
| JP2020208021A Active JP7242627B2 (ja) | 2011-05-18 | 2020-12-16 | 修飾依存的活性アッセイ |
| JP2023035124A Active JP7618714B2 (ja) | 2011-05-18 | 2023-03-08 | 修飾依存的活性アッセイ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8785139B2 (enExample) |
| EP (3) | EP3943939A1 (enExample) |
| JP (5) | JP6175426B2 (enExample) |
| AU (2) | AU2012255066B2 (enExample) |
| CA (1) | CA2836103C (enExample) |
| DK (2) | DK2710375T3 (enExample) |
| ES (2) | ES2720138T3 (enExample) |
| PL (2) | PL3517956T3 (enExample) |
| PT (2) | PT2710375T (enExample) |
| TR (1) | TR201904997T4 (enExample) |
| WO (1) | WO2012159084A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102375055A (zh) * | 2010-08-19 | 2012-03-14 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种多重检测免疫层析芯片 |
| US10745737B2 (en) * | 2012-11-09 | 2020-08-18 | Children's Medical Center Corporation | Methods and reagents for glycoproteomics |
| CN103819907B (zh) * | 2014-03-10 | 2016-04-06 | 山东理工大学 | 一种用聚丙二醇与聚乙烯醇对聚肽膜亲水性进行改进的方法 |
| WO2015169602A1 (en) * | 2014-05-05 | 2015-11-12 | Noviosmart | Method for the serological diagnosis of rheumatoid arthritis. |
| CN104559207B (zh) * | 2015-01-05 | 2017-02-22 | 山东理工大学 | 一种聚氨基甲酸酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法 |
| CN104559206B (zh) * | 2015-01-05 | 2017-02-22 | 山东理工大学 | 一种聚三亚甲基碳酸酯与聚丙烯酰胺改进聚肽膜亲水性与柔顺性的方法 |
| CN104448841B (zh) * | 2015-01-06 | 2016-08-31 | 山东理工大学 | 一种聚乳酸乙醇酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法 |
| CN104448843B (zh) * | 2015-01-06 | 2016-10-05 | 山东理工大学 | 一种聚己内酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法 |
| CN104448842B (zh) * | 2015-01-06 | 2016-08-31 | 山东理工大学 | 一种聚乳酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法 |
| CN104559224B (zh) * | 2015-01-12 | 2017-02-22 | 山东理工大学 | 一种聚丙二醇与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法 |
| CN104530722B (zh) * | 2015-01-12 | 2017-05-03 | 山东理工大学 | 一种聚乳酸乙醇酸与羧甲基壳聚糖改进聚肽膜亲水性与柔顺性的方法 |
| CN104479367B (zh) * | 2015-01-12 | 2016-08-31 | 山东理工大学 | 一种聚乳酸与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法 |
| US9804170B2 (en) | 2015-02-09 | 2017-10-31 | Bristol-Myers Squibb Company | Antibodies to polyethylene glycol |
| JP6552286B2 (ja) * | 2015-06-05 | 2019-07-31 | 公立大学法人奈良県立医科大学 | 凝固第ｖｉｉｉ因子の複合体形成能に関する情報の取得方法および試薬キット |
| SG11202107497XA (en) | 2019-01-23 | 2021-08-30 | Regeneron Pharma | Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors |
| US11845989B2 (en) | 2019-01-23 | 2023-12-19 | Regeneron Pharmaceuticals, Inc. | Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors |
| CN110118847B (zh) * | 2019-05-17 | 2021-08-10 | 重庆派金生物科技有限公司 | 确定多位点peg修饰蛋白质修饰位点的分析方法 |
| EP4298219A1 (en) | 2021-02-26 | 2024-01-03 | Regeneron Pharmaceuticals, Inc. | Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors |
| WO2023021311A1 (en) * | 2021-08-20 | 2023-02-23 | Takeda Pharmaceutical Company Limited | Selective measurement of human factor viii |
| CA3244889A1 (en) | 2022-03-08 | 2023-09-14 | Equashield Medical Ltd | FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3244030A1 (de) | 1982-11-27 | 1984-05-30 | Behringwerke Ag, 3550 Marburg | Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung |
| US5208148A (en) | 1990-12-07 | 1993-05-04 | Molecular Probes, Inc. | Lipophilic fluorescent glycosidase substrates |
| EP0603266B1 (en) | 1991-08-23 | 1999-05-12 | Molecular Probes, Inc. | Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells |
| US5576424A (en) | 1991-08-23 | 1996-11-19 | Molecular Probes, Inc. | Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells |
| US5242805A (en) | 1991-08-23 | 1993-09-07 | Molecular Probes, Inc. | Long wavelength lipophilic fluorogenic glycosidase substrates |
| US5830912A (en) | 1996-11-15 | 1998-11-03 | Molecular Probes, Inc. | Derivatives of 6,8-difluoro-7-hydroxycoumarin |
| US5773236A (en) | 1997-04-25 | 1998-06-30 | Molecule Probes, Inc. | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules |
| CN1688248A (zh) * | 2002-08-22 | 2005-10-26 | 贝克顿·迪金森公司 | 痴呆相关神经疾病的诊断方法 |
| US8133865B2 (en) | 2006-12-27 | 2012-03-13 | Nektar Therapeutics | von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage |
| US9333247B2 (en) * | 2007-07-03 | 2016-05-10 | Children's Hospital & Research Center At Oakland | Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| ES2587742T3 (es) * | 2007-12-27 | 2016-10-26 | Baxalta GmbH | Métodos para diferenciar en una muestra proteína derivada de plasma de proteína recombinante |
| ES2515365T3 (es) * | 2007-12-27 | 2014-10-29 | Baxter International Inc. | Procedimiento y composiciones para detectar específicamente moléculas poliméricas fisiológicamente aceptables |
| BRPI0911266A2 (pt) * | 2008-04-03 | 2015-09-29 | Hoffmann La Roche | ensaio de fator de crescimento similar à insulina peguilado |
| CA2740904C (en) * | 2008-10-21 | 2019-01-15 | Baxter International Inc. | Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation) |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| EP3081233B1 (en) | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation of proteins other than blood coagulation proteins |
| AU2010281453C1 (en) | 2009-07-27 | 2019-08-15 | Takeda Pharmaceutical Company Limited | Blood coagulation protein conjugates |
| GB2488532B (en) * | 2011-02-18 | 2013-06-05 | Sca Ipla Holdings Inc | Communication units and methods for control change notification in broadcast communication |
-
2012
- 2012-05-18 WO PCT/US2012/038704 patent/WO2012159084A1/en not_active Ceased
- 2012-05-18 ES ES12725954T patent/ES2720138T3/es active Active
- 2012-05-18 JP JP2014511600A patent/JP6175426B2/ja active Active
- 2012-05-18 TR TR2019/04997T patent/TR201904997T4/tr unknown
- 2012-05-18 PL PL19161002T patent/PL3517956T3/pl unknown
- 2012-05-18 PL PL12725954T patent/PL2710375T3/pl unknown
- 2012-05-18 AU AU2012255066A patent/AU2012255066B2/en active Active
- 2012-05-18 PT PT12725954T patent/PT2710375T/pt unknown
- 2012-05-18 CA CA2836103A patent/CA2836103C/en active Active
- 2012-05-18 EP EP21190282.0A patent/EP3943939A1/en active Pending
- 2012-05-18 US US13/475,634 patent/US8785139B2/en active Active
- 2012-05-18 EP EP19161002.1A patent/EP3517956B1/en active Active
- 2012-05-18 DK DK12725954.7T patent/DK2710375T3/en active
- 2012-05-18 ES ES19161002T patent/ES2893605T3/es active Active
- 2012-05-18 DK DK19161002.1T patent/DK3517956T3/da active
- 2012-05-18 PT PT191610021T patent/PT3517956T/pt unknown
- 2012-05-18 EP EP12725954.7A patent/EP2710375B1/en active Active
-
2016
- 2016-05-24 AU AU2016203387A patent/AU2016203387B2/en active Active
-
2017
- 2017-04-13 JP JP2017079848A patent/JP2017161536A/ja active Pending
-
2018
- 2018-11-08 JP JP2018210141A patent/JP6863950B2/ja active Active
-
2020
- 2020-12-16 JP JP2020208021A patent/JP7242627B2/ja active Active
-
2023
- 2023-03-08 JP JP2023035124A patent/JP7618714B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014524010A5 (enExample) | ||
| JP7618714B2 (ja) | 修飾依存的活性アッセイ | |
| Firestein et al. | Quantitative analysis of cytokine gene expression in rheumatoid arthritis. | |
| Lathrop et al. | Therapeutic potential of the plasma proteome | |
| CA2642648C (en) | Detection of anthrax pathogenicity factors | |
| RU2522231C1 (ru) | Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления | |
| DE50014975D1 (de) | Verfahren zur Reindarstellung des Proenzyms der den Blutgerinnungsfaktor VII aktivierenden Protease mittels Ionenaustauscherchromatographie | |
| JP2006507004A (ja) | プロテアーゼ酵素の検出 | |
| Ohnishi et al. | Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects | |
| JP2021523378A (ja) | タンパク質の定量分析 | |
| James et al. | The effect of α2 macroglobulin in commercial cytokine assays | |
| CN119375379A (zh) | 一种基于lc-ms/ms的相思子毒素活性的检测方法 | |
| EP1504265B1 (en) | Sandwich assay | |
| WO2014007242A1 (ja) | Ｈｂ－ｅｇｆの測定方法 | |
| Proost et al. | Posttranslational processing of chemokines | |
| JPS6113156A (ja) | ヒトインタ−フエロン−αの定量用試薬及び定量法 | |
| WO2005114196A1 (ja) | 間質性膀胱炎の検査方法 | |
| HK40067577A (en) | Modification-dependent activity assays | |
| HK40010723B (en) | Modification-dependent activity assays | |
| HK40010723A (en) | Modification-dependent activity assays |